• search

Elder Pharma inks alliance with medical disinfection major

Written by: Staff

Mumbai, Apr 11 (UNI) In consonance with its strategy of focussing on emerging segments, Indian pharma major Elder Pharmaceuticals Limited has entered the medical disinfection segment in its bid to expand the business.

The Rs. 375-crore pharma major has inked an alliance with the UK-based M/s Medichem International, a leader in advanced medical disinfection products, to develop, manufacture and market advanced medical biosecurity products in India.

A release issued here today stated that Elder has initially commenced marketing of a spray called Trigene, used for precaution against potential risk from the H5N1 avian flu virus.

The release said that Trigene is effective in containing the spread of bird flu in hospitals, poultry farms, kennels, catteries and other animal habitats and has met with tremendous success since its launch last year, particularly in China.

In view of the excellent response received from a few hospitals in Mumbai, Elder is working out plans to manufacture this and similar other products of Medichem in India at its newly set up US FDA compliant Uttaranchal facility, the release pointed out.

Once it starts manufacturing these products, Elder plans to take them to the medical, laboratory, veterinary, environmental, military and government sectors within the country in the current year and expects to generate a turnover of Rs. 18-20 crore in the first year itself from this business.

Mr. Alok Saxena, Director, Elder Pharmaceuticals, said ''Elder's entry into the medical disinfection sector is a part of its strategy of focussing on emerging segments and manufacturing world-class products in India through in-licenses with global majors.'' UNI JJ ADG VKG1550

For Daily Alerts

For Breaking News from Oneindia
Get instant news updates throughout the day.

Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more